Stock comparison
Merck & Co., Inc. is 28.0x more valuable than Abivax S.A. by market capitalization ($305.44 B vs $10.92 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 28.0x more valuable than Abivax S.A. by market capitalization ($305.44 B vs $10.92 B).
Market value leader
MRK
Merck & Co., Inc. is 28.0x more valuable than Abivax S.A. by market capitalization ($305.44 B vs $10.92 B).
| Metric | ABVX | MRK |
|---|---|---|
| Market cap | $10.92 B | $305.44 B |
| US-listed rank | #902 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.7x |
| SEC filings | 92 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 28.0x more valuable than Abivax S.A. by market capitalization ($305.44 B vs $10.92 B).
Full pages: Abivax S.A. and Merck & Co., Inc., or browse the full rankings.